In accordance with microarray and qRT-PCR data, GDF15 levels were increased in plasma (14-fold) during carboplatin short-treatment in A2780 tumor-bearing mice compared to vehicle treatment, but only slightly (twofold) in A2780cis tumor-bearing mice. This evidence concerns the gene GDF15 and neoplasm.